Metastatic mammary carcinomas with endocrine features: Potential diagnostic pitfalls

• Published in: Diagnostic cytopathology 2005-07, Vol.33 (1), p.49-53
• Main Authors: Saqi, Anjali, Oster, Martin W., Vazquez, Madeline F.
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Biopsy, Fine-Needle; breast; Breast - chemistry; Breast - pathology; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; carcinoid; carcinoma; Carrier Proteins - analysis; Chromogranins - analysis; Diagnosis, Differential; endocrine; Endocrine Glands - pathology; Female; Glycoproteins - analysis; Humans; Immunohistochemistry; Lung Neoplasms - metabolism; Lung Neoplasms - secondary; metastases; Middle Aged; neuroendocrine; Receptor, ErbB-2 - analysis; Receptors, Estrogen - analysis; Receptors, Progesterone - analysis; Synaptophysin - analysis
• ISSN: 8755-1039; 1097-0339
• DOI: 10.1002/dc.20298

Mammary carcinomas with endocrine differentiation (MCED) are an uncommon subtype of breast carcinomas that are morphologically indistinguishable from low‐grade endocrine neoplasms arising in other organs. Aspirates of MCED yield relatively monotonous cells with eccentrically placed nuclei containing characteristic “salt and pepper” chromatin. In the breast, these features represent MCED. In extramammary sites, the differential is more extensive, and diagnosing MCED metastates to the lung, a common location for primary and metastatic endocrine tumors, can be a challenging task, with significant clinical implications. Although primary MCED have been described extensively in the cytology literature, secondary pulmonary MCED have not been reported to the best of our knowledge. We report three cases of MCED metastatic to the lung and present the cytological and immunohistochemical features. Diagn. Cytopathol. 2005;33:49–53. © 2005 Wiley‐Liss, Inc.